Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder	Active, not recruiting	Phase 2	2026-01-05		NCT01196936

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
City of Hope National Medical Center	8
Dana-Farber Cancer Institute	324
M.D. Anderson Cancer Center	1145
Mayo Clinic	970
National Cancer Institute (NCI)	3015
St. Jude Children's Research Hospital	169
University Health Network, Toronto	417
University of Alabama at Birmingham	467
University of Chicago	326
University of Colorado, Denver	475
University of Michigan	394
University of Minnesota	344
University of Washington	397
Wake Forest University	35

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
City of Hope Medical Center	Duarte	United States	313
Dana-Farber Cancer Institute	Boston	United States	68
Mayo Clinic	Rochester	United States	664
MD Anderson	Houston	United States	56
Seattle Cancer Care Alliance	Seattle	United States	36
St. Jude Children's Research Hospital	Memphis	United States	194
University Health Network, Toronto	Toronto	Canada	2
University of Alabama at Birmingham	Birmingham	United States	193
University of Chicago	Chicago	United States	312
University of Colorado, Anschutz Medical Campus	Aurora	United States	8
University of Michigan	Ann Arbor	United States	1
University of Minnesota	Minneapolis	United States	325
Wake Forest University	Winston-Salem	United States	22